SAN FRANCISCO, April 18, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm reminds Williams Partners L.P. (NYSE:WPZ) investors of the May 6, 2016 lead plaintiff deadline in the securities fraud class action lawsuit regarding false and misleading statements to investors about an acquisition of WPZ by The Williams Companies.
If you suffered significant losses because of your purchases of WPZ between May 13, 2015 and June 19, 2015, or have information that will help our investigation contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation by calling 510-725-3000, emailing [email protected] or visiting https://www.hbsslaw.com/cases/WPZ. The lawsuit was filed in the U.S. District Court for the Northern District of Oklahoma and investors have until May 6, 2016 to move the court to participate as a lead plaintiff.
On May 13, 2015, WPZ and The Williams Companies, Inc. (“WMB”) jointly announced that an agreement had been executed to merge the two entities. The agreement provided that WMB would acquire all publicly-held WPZ common units at a 1.115 ratio of WMB common share per WPZ common unit. In response to this news, the price of WPZ common units rose 22.7% that day.
However, as alleged in the complaint, Defendants failed to disclose to WPZ investors that before and after the May 13, 2015 merger announcement, WMB was negotiating to sell itself to Energy Transfer Equity (“ETE”). On June 19, 2015, ETE submitted its written offer to acquire WMB for an implied price of $64.00 per WMB common share and was conditioned on terminating the WPZ/WMB merger agreement. On June 22, 2015, ETE publicly announced its offer, including the requirement that WMB terminate the WPZ/WMB merger agreement. In response to this news, the price of WPZ common units fell 7.6% while the price of WMB common stock rose nearly 26% that day.
The complaint also alleges that Defendants’ false and misleading statements and knowing failures to disclose ETE’s interest in WMB to WPZ investors when the WPZ/WMB merger agreement was announced on May 13, 2015 artificially inflated the price for WPZ common units at all relevant times.
Whistleblowers: Persons with non-public information regarding Williams Partners should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


FDA Approves Mitapivat for Anemia in Thalassemia Patients
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 



